Ampio Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Ampio Pharmaceuticals has a total shareholder equity of $5.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $7.6M and $2.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$6.43m |
| Equity | US$5.38m |
| Total liabilities | US$2.27m |
| Total assets | US$7.65m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: APH's short term assets ($7.6M) exceed its short term liabilities ($2.3M).
Long Term Liabilities: APH has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: APH is debt free.
Reducing Debt: APH had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: APH has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: APH has less than a year of cash runway if free cash flow continues to reduce at historical rates of 6.1% each year